Skip to main content

Table 1 Five Level Risk Stratification for prostate cancer. [6]

From: Expanded risk groups help determine which prostate radiotherapy sub-group may benefit from adjuvant androgen deprivation therapy

 

Risk Factor

Risk Group

PSA

Gleason

T-Stage

1. Low

<7.5

≤ 6

any

2. Low-intermediate

7.5–15

≤ 6

any

3. High-intermediate

15–20

≤ 6

any

 

≤ 10

≥ 7

any

4. High

20–30

≤ 6

any

 

10–20

≥ 7

any

5. Extreme

>20

≥ 7

any

 

>30

≤ 6

any

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us